|
|
||||||||
Papers In Press, published online ahead of print May 16, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Faculté de Médecine, Université de Bretagne Occidentale, BREST 29285
Corresponding Author: jp.salaun{at}univ-brest.fr
CYP4F isoforms are involved in the oxidation of important cellular mediators such as leukotriene B4 (LTB4)1 and prostaglandins. The proinflammatory agent LTB4 and cytotoxic leukotoxins were associated with several inflammatory diseases. We report on the hydroxylation of Z9,10-epoxyoctadecanoic, Z9,10-epoxyoctadec-Z12-enoic, Z12,13-epoxyoctadec-Z9-enoic acids and that of monoepoxides from arachidonic acid (EET) as a mechanism for regulation of leukotoxin and EET activity. The three C18-epoxides were converted to 18-hydroxy-C18-epoxides by human hepatic microsomes with apparent Km within 27.6 and 175 µM. Among P450 recombinants, CYP4F2 and 4F3B catalyzed mainly the -hydroxylation of C18-epoxides with Vmax within 0.84 to 15.0 min-1, whereas the Vmax displayed by CYP4F3A, the isoform found in leukocytes, ranged from 3.0 to 21.2 min-1. A rate of omega-hydroxylation by CYP4A11 was experimentally found within 0.3 and 2.7 min-1. CYP4F2 and CYP4F3 exhibited preference for omega-hydroxylation of 8,9-EET, whereas human liver microsomes preferred 11,12-EET followed by 8,9-EET. Moreover, conjugated diols from both C18-epoxides and EETs were omega-hydroxylated by liver microsomes and by CYP4F2 and CYP4F3. These data support the hypothesis that the human CYP4F subfamily is involved in the omega-hydroxylation of fatty acid epoxides. These findings demonstrated that another pathway besides conversion to diols exists for fatty acid epoxides inactivation.
Revised on April 8, 2004
Accepted on May 4, 2004
Human CYP4F3 are the main catalysts in the oxidation of fatty acid epoxides
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. Fer, L. Corcos, Y. Dreano, E. Plee-Gautier, J.-P. Salaun, F. Berthou, and Y. Amet Cytochromes P450 from family 4 are the main omega hydroxylating enzymes in humans: CYP4F3B is the prominent player in PUFA metabolism J. Lipid Res., November 1, 2008; 49(11): 2379 - 2389. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Antoun, S. Goulitquer, Y. Amet, Y. Dreano, J.-P. Salaun, L. Corcos, and E. Plee-Gautier CYP4F3B is induced by PGA1 in human liver cells: a regulation of the 20-HETE synthesis J. Lipid Res., October 1, 2008; 49(10): 2135 - 2141. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kalsotra, L. Du, Y. Wang, P. A. Ladd, Y. Kikuta, M. Duvic, A. S. Boyd, D. S. Keeney, and H. W. Strobel Inflammation resolved by retinoid X receptor-mediated inactivation of leukotriene signaling pathways FASEB J, February 1, 2008; 22(2): 538 - 547. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gatica, M. C. Aguilera, D. Contador, G. Loyola, C. O. Pinto, L. Amigo, J. E. Tichauer, S. Zanlungo, and M. Bronfman P450 CYP2C epoxygenase and CYP4A {omega}-hydroxylase mediate ciprofibrate-induced PPAR{alpha}-dependent peroxisomal proliferation J. Lipid Res., April 1, 2007; 48(4): 924 - 934. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gaedigk, D. W. Baker, R. A. Totah, R. Gaedigk, R. E. Pearce, C. A. Vyhlidal, D. C. Zeldin, and J. S. Leeder Variability of CYP2J2 Expression in Human Fetal Tissues J. Pharmacol. Exp. Ther., November 1, 2006; 319(2): 523 - 532. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-Q. Yin, M. Kim, J.-H. Kim, G. Kong, M.-O. Lee, K.-S. Kang, B.-I. Yoon, H.-L. Kim, and B.-H. Lee Hepatic Gene Expression Profiling and Lipid Homeostasis in Mice Exposed to Steatogenic Drug, Tetracycline Toxicol. Sci., November 1, 2006; 94(1): 206 - 216. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. C. Kupper, E. Gaquerel, E.-M. Boneberg, S. Morath, J.-P. Salaun, and P. Potin Early events in the perception of lipopolysaccharides in the brown alga Laminaria digitata include an oxidative burst and activation of fatty acid oxidation cascades J. Exp. Bot., June 1, 2006; 57(9): 1991 - 1999. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |